Wednesday, April 08, 2015 11:29:18 PM
All things considered, I'm glad I did not sell ADX? and buy MVTG just because yesterday one was at the 52 week high and the other set a new 52 week low. A look at their respective charts will show you why.
Sometimes I sell the top of range and buy the new lows on heavy volume to take some profits and lower risk. In this case, the immunotherapy development-stage biotech soared to a new 52 week high today following the breakout of multiple tops and the innovative fuel cell stock here may, IMO, be in the doldrums for a while.
There's been enough pointed criticism today to bring forth Ganter50's extended and helpful explanations of possible IP issues. Makes the stock worth watching and waiting. In my case the company will have to make a compelling case and advance both business and technology aspects to compensate for the delay. We will see.
Recent HWNI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM